Home › Funds › Vitruvian Partners LLP › RXST

Vitruvian Partners LLP position in RXST

RXSIGHT INC · Health Care

Vitruvian Partners LLP reported holding 278,865 shares of RXST (RXSIGHT INC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.21% of its reported portfolio and ranking #8 among its reported holdings. Vitruvian Partners LLP has disclosed RXST holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)278.87K sh
Reported value held$1.37M
Portfolio Weight1.21%
First reportedQ4 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vitruvian Partners LLP's RXST position evolved

Vitruvian Partners LLP first disclosed a stake in RXST in Q4 2024 at 144,300 shares (US$5.0M). The position peaked in Q1 2025 at 230,743 shares, worth US$5.8M. Across 8 filings, Vitruvian Partners LLP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 278,865 shares valued at US$1.4M. Notable position changes include a 60% increase in Q1 2025 (shares fell 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 144.30K $4.96M New
Q1 2025 230.74K $5.83M Add
Q2 2025 230.74K $3.00M Hold
Q3 2025 230.74K $2.07M Hold
Q4 2025 278.87K $2.91M Add
Q1 2026 278.87K $1.72M Hold
Q2 2026 278.87K $1.34M Hold
Q3 2026 278.87K $1.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RXST and 13F data

RXST (RXSIGHT INC) is a Health Care company. 9 other funds we track also report a position in RXST — the largest reported positions include No Street GP LP (US$9.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RXST

All RXST fund holders →

FAQ

How long has Vitruvian Partners LLP held RXST?

Vitruvian Partners LLP has disclosed RXST holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Vitruvian Partners LLP's current position in RXST?

As of Q3 2026, Vitruvian Partners LLP holds 278.87K shares of RXST (RXSIGHT INC), valued at $1.37M, representing 1.21% of its reported portfolio and ranking #8.

Has Vitruvian Partners LLP been buying or selling RXST?

In the latest 13F filing (Q3 2026), Vitruvian Partners LLP held unchanged its position in RXST. The position peaked in Q1 2025 at 230.74K shares.

Which other funds hold RXST?

Other major institutional holders of RXST include No Street GP LP, among 9 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.